A recent study provided evidence that ST6Gal-1, a sialyltransferase that adds sialic acid residues to the N-glycans of certain membrane receptors, is a marker of colon cancer stem cells [392]. This evidence concerns the gene ST6GAL1 and colonic neoplasm.